Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-03-27
1994-01-11
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514365, 514400, 514407, 514438, 514530, 514540, 514548, 514551, 514616, 514620, 514626, 548214, 5483355, 5483381, 5483731, 5483751, 5483365, 549 75, 549 76, 549 77, 560 19, 560 37, 560 38, 560155, 560157, 560159, 560169, 564164, 564192, 564193, 564194, 564196, 564197, A61K 3702, A61K 3743, C07K 506, C07K 508, C07C23308, C07C23502, C07C23702
Patent
active
052781488
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sup.1 is hydrogen or methyl, R.sup.2 is ethyl, propyl, isopropyl, imidazol-2-yl, imidazol-4-yl, pyrazol-3-yl, thiazol-4-yl, thien-2-yl, ethoxycarbonyl, t-butylcarbonylmethyl, benzyloxycarbonylmethyl or t-butoxy, R.sup.3 is isobutyl, cyclohexylmethyl or benzyl, R.sup.4 is nitro, amino or a group of the formula --N(R.sup.5)(R.sup.6) and A is one of the groups ##STR2## wherein R.sup.5 and R.sup.6 is alkyl or alkoxyalkyl; or optionally substituted phenyl, phenylalkyl or phenylsulfonylalkyl among others with the proviso that A is not group (b) when R.sup.6 is alkanoyl, alkoxycarbonyl or arylalkoxycarbonyl, the dotted line can be an additional bond, R.sup.7 is phenyl or substituted phenyl and R.sup.8 is hydrogen or organocarbonylalkyl, with the proviso that R.sup.8 is not alkoxycarbonylamino or arylalkoxycarbonylamino when R.sup.7 is phenyl, benzyl or .alpha.-naphthyl, Y is a bivalent residue in the form of optically pure diastereomers, mixtures of diastereomers, diastereomeric racemates or mixtures of diastereomeric racemates as well as pharmaceutically usable salts thereof inhibit the activity of the natural enzyme renin and can accordingly be used in the control or prevention of high blood pressure and cardiac insufficiency.
REFERENCES:
patent: 4613676 (1986-09-01), Fuhrer et al.
patent: 4713445 (1987-12-01), Szelke et al.
patent: 4725583 (1988-02-01), Luly et al.
patent: 4727060 (1988-02-01), Buhlmayer et al.
patent: 4749781 (1988-06-01), Gordon
patent: 4826815 (1989-05-01), Luly et al.
patent: 4826958 (1989-05-01), Sham
patent: 4837204 (1989-06-01), Rosenberg
patent: 4845079 (1989-07-01), Luly et al.
patent: 4857507 (1989-08-01), Rosenberg et al.
patent: 4857650 (1989-08-01), Iizuka et al.
patent: 4885292 (1989-12-01), Ryono et al.
patent: 4931591 (1990-06-01), Buhlmayer et al.
Burger, A. Medicinal Chemistry, Second Edition, New York (1960), pp. 565-571, 578-581, 600-601.
Plattner et al., J. Med. Chem., (31) 1988, pp. 2277-2288.
Bolis et al., J. Med. Chem., (30) 1987, pp. 1729-1737.
Denkewalter et al., Progress in Drug Research, vol. 10, 1966, pp. 510-512.
Branca Quirico
Marki Hans P.
Neidhart Werner
Ramuz Henri
Wostl Wolfgang
Gould George M.
Higel Floyd D.
Hoffmann-La Roche Inc.
Johnston George W.
Parise John P.
LandOfFree
Amino acid derivatives useful for treating high blood pressure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivatives useful for treating high blood pressure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivatives useful for treating high blood pressure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631340